Case Report: Brucella melitensis-associated HLH in a child
Abstract
Brucella melitensis -associated hemophagocytic lymphohistiocytosis (HLH) is rare in children, and its clinical recognition can be challenging because early manifestations overlap with those of infection. The potential contribution of host genetic factors to infection-associated hyperinflammation also remains unclear. We report a previously healthy 9-year-old boy with a history of raw sheep milk consumption who developed persistent high-grade fever. Blood culture confirmed B. melitensis infection. Persistent fever, splenomegaly, marked hyperferritinemia, bone marrow hemophagocytosis, and evolving hematological abnormalities supported a clinical diagnosis of secondary HLH, although only four HLH-2004 diagnostic criteria were documented. Corticosteroids and a single dose of etoposide were administered before the infectious etiology was established, followed by targeted anti- Brucella antimicrobial therapy. The patient showed substantial clinical and hematological improvement, with no clinical evidence of relapse during follow-up. Genetic testing identified a heterozygous UNC13D c.118-9G>C variant classified as a variant of uncertain significance (VUS), which was insufficient to establish a molecular diagnosis of primary HLH and whose functional significance remains unknown. This case highlights the diagnostic challenges of Brucella -associated secondary HLH in children. Although a heterozygous UNC13D variant was identified, its biological significance remains uncertain, and whether host genetic susceptibility contributes to infection-triggered hyperinflammation requires further investigation.